Stock Market Live June 8, 2026: S&P 500 (SPY) Rebounds with Chip Stocks

Health and Healthcare

BioNTech : BNTX

All BioNTech Articles

42 Articles

Jon C. Ogg | Oct 28, 2020 at 7:01 PM EDT

Did Regeneron Just Revive Hopes About Beating COVID-19?

The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in…

Chris Lange | Oct 16, 2020 at 10:46 AM EDT

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s…

Jon C. Ogg | Oct 14, 2020 at 9:01 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton, Salesforce, Williams-Sonoma and More

Wednesday's top analyst upgrades and downgrades included Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton Interactive, Salesforce.com and Williams-Sonoma.

Jon C. Ogg | Oct 5, 2020 at 1:28 PM EDT

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Chris Lange | Aug 21, 2020 at 9:35 AM EDT

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and…

Jon C. Ogg | Aug 6, 2020 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair…

Chris Lange | Jul 28, 2020 at 8:46 AM EDT

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead…

Chris Lange | Jul 22, 2020 at 10:04 AM EDT

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in…

Chris Lange | Jul 21, 2020 at 11:23 AM EDT

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than…

Chris Lange | Jul 20, 2020 at 9:52 AM EDT

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news…

1 2 3

BioNTech : BNTX

All BioNTech Articles

Did Regeneron Just Revive Hopes About Beating COVID-19?

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Top Analyst Upgrades and Downgrades: Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton, Salesforce, Williams-Sonoma and More

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

What Does a Perfect COVID-19 Vaccine Actually Mean?

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

Stock Market Live June 8, 2026: S&P 500 (SPY) Rebounds with Chip Stocks

Live Nasdaq Composite: Nasdaq Snaps Back as Chip Stocks Rebound and AI Tailwinds Hold Firm

Forget Intel Corporation: As Rising Yields Shake Wall Street, This Unstoppable AI Powerhouse Is a No-Brainer Buy

The Odds of a Fed Rate Hike Passed 50% This Weekend. Is the Trump and Warsh Honeymoon Over Already?

Clean Energy Is the S&P 500’s New Boss: ACES Up 29% YTD

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

The Cost Segregation Study a 58-Year-Old Landlord Just Used to Deduct $186,000 of Rental Depreciation in the First Year

Forget Intel Corporation: As Rising Yields Shake Wall Street, This Unstoppable AI Powerhouse Is a No-Brainer Buy

The Odds of a Fed Rate Hike Passed 50% This Weekend. Is the Trump and Warsh Honeymoon Over Already?

BioNTech : BNTX

All BioNTech Articles

Did Regeneron Just Revive Hopes About Beating COVID-19?

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Top Analyst Upgrades and Downgrades: Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton, Salesforce, Williams-Sonoma and More

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

What Does a Perfect COVID-19 Vaccine Actually Mean?

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Pfizer and BioNTech Close in COVID-19 Vaccine With This Next Big Step

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

Stock Market Live June 8, 2026: S&P 500 (SPY) Rebounds with Chip Stocks

Live Nasdaq Composite: Nasdaq Snaps Back as Chip Stocks Rebound and AI Tailwinds Hold Firm

Forget Intel Corporation: As Rising Yields Shake Wall Street, This Unstoppable AI Powerhouse Is a No-Brainer Buy

The Odds of a Fed Rate Hike Passed 50% This Weekend. Is the Trump and Warsh Honeymoon Over Already?

Clean Energy Is the S&P 500’s New Boss: ACES Up 29% YTD

Featured Reads

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

The Cost Segregation Study a 58-Year-Old Landlord Just Used to Deduct $186,000 of Rental Depreciation in the First Year